{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:36:11Z","timestamp":1773761771041,"version":"3.50.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.0B23.17N"],"award-info":[{"award-number":["G.0B23.17N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI15\/00713"],"award-info":[{"award-number":["PI15\/00713"]}]},{"name":"Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER","award":["RD16\/0025\/0040"],"award-info":[{"award-number":["RD16\/0025\/0040"]}]},{"name":"Fundaci\u00f3n Progreso y salud, Junta de Andaluc\u00eda","award":["PI-0411-2014"],"award-info":[{"award-number":["PI-0411-2014"]}]},{"name":"GEHEP-SEIMC","award":["GEHEP-004"],"award-info":[{"award-number":["GEHEP-004"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201268","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T17:44:10Z","timestamp":1532540650000},"page":"e0201268","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-8752","authenticated-orcid":true,"given":"Lize","family":"Cuypers","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-817X","authenticated-orcid":true,"given":"Ana Bel\u00e9n","family":"P\u00e9rez","sequence":"additional","affiliation":[]},{"given":"Natalia","family":"Chueca","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Aldamiz-Echevarr\u00eda","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5361-3968","authenticated-orcid":true,"given":"Juan Carlos","family":"Alados","sequence":"additional","affiliation":[]},{"given":"Ana Mar\u00eda","family":"Mart\u00ednez-Sapi\u00f1a","sequence":"additional","affiliation":[]},{"given":"Dolores","family":"Merino","sequence":"additional","affiliation":[]},{"given":"Juan Antonio","family":"Pineda","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"T\u00e9llez","sequence":"additional","affiliation":[]},{"given":"Nuria","family":"Espinosa","sequence":"additional","affiliation":[]},{"given":"Javier","family":"Salm\u00e9ron","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Rivero-Juarez","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda Jes\u00fas","family":"Vivancos","sequence":"additional","affiliation":[]},{"given":"V\u00edctor","family":"Honta\u00f1\u00f3n","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-2766","authenticated-orcid":true,"given":"Anne-Mieke","family":"Vandamme","sequence":"additional","affiliation":[]},{"given":"F\u00e9derico","family":"Garc\u00eda","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006292","article-title":"The blood DNA virome in 8,000 humans","volume":"13","author":"A Moustafa","year":"2017","journal-title":"PLoS Pathog"},{"key":"ref2","article-title":"EASL recommendations on treatment of hepatitis C 2018","year":"2018","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/rmv.1895","article-title":"Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time","volume":"26","author":"L Cuypers","year":"2016","journal-title":"Rev Med Virol"},{"key":"ref4","first-page":"274","article-title":"Protective immunity against hepatitis C: many shades of gray","volume":"5","author":"MS Abdel-Hakeem","year":"2014","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jhep.2016.07.039","article-title":"Reversion of disease manifestations after HCV eradication","volume":"65","author":"AJ van der Meer","year":"2016","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jmv.21050","article-title":"Change in hepatitis C virus genotype in hemodialysis patients after end-of-treatment response to interferon monotherapy -relapse or re-infection?","volume":"80","author":"TC Arrais","year":"2008","journal-title":"J Med Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jhep.2009.05.027","article-title":"Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam","volume":"51","author":"TJ van de Laar","year":"2009","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/QAD.0b013e32836381cc","article-title":"Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM","volume":"27","author":"TC Martin","year":"2013","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis","volume":"62","author":"B Simmons","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrgastro.2015.36","article-title":"Mixed HCV infection and reinfection in people who inject drugs\u2014impact on therapy","volume":"12","author":"EB Cunningham","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2013.03.008","article-title":"Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C","volume":"59","author":"A Marco","year":"2013","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S2468-1253(16)30182-0","article-title":"Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study","volume":"2","author":"N Islam","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jinf.2017.05.008","article-title":"Direct-acting antiviral treatment against hepatitis C virus infection in HIV-infected patients\u2013\u201cEn route for eradication\u201d?","volume":"75","author":"P Pradat","year":"2017","journal-title":"J Infect"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrgastro.2017.106","article-title":"Direct-acting antiviral agents for HCV infection affecting people who inject drugs","volume":"14","author":"J Grebely","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM","volume":"25","author":"FA Lambers","year":"2011","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/QAD.0000000000001522","article-title":"MSM starting preexposure prohylaxis are at risk of hepatitis C virus infection","volume":"31","author":"E Hoornenborg","year":"2017","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cid\/ciw676","article-title":"Late relapse versus hepatitis C virus reinfection in patients with sustained virologic response after sofosbuvir-based therapies","volume":"64","author":"C Sarrazin","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1016\/S0168-8278(17)30947-9","article-title":"Real-life retreatment of patients failing DAAs in Spain: data from the HCVREsp GEHEP-004 cohort","volume":"66","author":"AB P\u00e9rez","year":"2017","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/135965350901400314","article-title":"Virological relapse in chronic hepatitis C","volume":"14","author":"FF Poordad","year":"2009","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/JCM.02093-14","article-title":"High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods","volume":"53","author":"J Quer","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku739","article-title":"COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification","volume":"42","author":"D Struck","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"T de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","article-title":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","volume":"73","author":"KS Lole","year":"1999","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drup.2018.01.004","article-title":"Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018","volume":"37","author":"MC Sorbo","year":"2018","journal-title":"Drug Resist Updat"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"C Camacho","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/molbev\/msp259","article-title":"Seaview version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building","volume":"27","author":"M Gouy","year":"2010","journal-title":"Mol Biol Evol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for bigger datasets","volume":"33","author":"S Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-1-4939-6622-6_17","article-title":"Detecting and analyzing genetic recombination using RDP4","volume":"1525","author":"DP Martin","year":"2017","journal-title":"Methods Mol Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/bioinformatics\/18.3.502","article-title":"TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing","volume":"18","author":"HA Schmidt","year":"2002","journal-title":"Bioinformatics"},{"key":"ref30","first-page":"5","article-title":"FastTree 2 \u2013approximately maximum-likelihood trees for large alignments","author":"MN Price","year":"2010","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/0471250953.bi0614s51","article-title":"Using RAxML to infer phylogenies","volume":"51","author":"A Stamatakis","year":"2015","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref32","unstructured":"AASLD 2017. Recommendations for testing, managing, and treating hepatitis C. Update September 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcvguidelines.org\/full-report-view\" xlink:type=\"simple\">http:\/\/www.hcvguidelines.org\/full-report-view<\/ext-link>"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/QAI.0000000000000528","article-title":"Risk factors for HCV acquisition among HIV-positive MSM in Belgium","volume":"68","author":"L Apers","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1097\/QAD.0000000000000834","article-title":"Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men","volume":"29","author":"H Hagan","year":"2015","journal-title":"AIDS"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/QAD.0000000000000126","article-title":"Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995\u20132010","volume":"28","author":"AT Urbanus","year":"2014","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10620-007-9856-7","article-title":"A comparison of risk factors for HCV-mono-infection, HIV-mono-infection, and HCV\/HIV-co-infection in a community setting","volume":"53","author":"S Bollepalli","year":"2008","journal-title":"Dig Dis Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1071\/SH13042","article-title":"HIV and hepatitis C virus co-infection among men who have sex with men in Sydney, and associations with sexual and drug use practices","volume":"10","author":"T Lea","year":"2013","journal-title":"Sex Health"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/jvh.12700","article-title":"Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000\u20132015 period (the GEHEP 005 study)","volume":"24","author":"A Aguilera","year":"2017","journal-title":"J Viral Hepat"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"44947","DOI":"10.1038\/srep44947","article-title":"The epidemic dynamics of hepatitis c virus subtypes 4a and 4d in Saudi Arabia","volume":"7","author":"AA Al-Qahtani","year":"2017","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.27310","article-title":"Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada","volume":"60","author":"B Jacka","year":"2014","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2016.02.031","article-title":"Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada","volume":"64","author":"B Jacka","year":"2016","journal-title":"J Hepatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2148-11-131","article-title":"The mode and tempo of hepatitis C virus evolution within and among hosts","volume":"11","author":"RR Gray","year":"2011","journal-title":"BMC Evol Biol"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185866","article-title":"Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users","volume":"12","author":"S Paraschiv","year":"2017","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.meegid.2015.04.017","article-title":"A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events","volume":"33","author":"AD Olmstead","year":"2015","journal-title":"Infect Genet Evol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/01.aids.0000182519.92030.ce","article-title":"Exploring full-genome sequences for phylogenetic support of HIV-1 transmission events","volume":"19","author":"P Lemey","year":"2005","journal-title":"AIDS"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/v3102006","article-title":"Recombination in hepatitis C virus","volume":"3","author":"F Gonz\u00e1lez-Candelas","year":"2011","journal-title":"Viruses"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.27895","article-title":"Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct acting antivirals","volume":"63","author":"F Ceccherini Silberstein","year":"2016","journal-title":"Hepatology"},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153754","article-title":"Using NS5B sequencing for hepatitis C virus genotyping reveals discordances with commercial platforms","volume":"11","author":"N Chueca","year":"2016","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175564","article-title":"The cobas\u00ae HCV GT is a new tool that accurately identifies hepatitis C virus genotypes for clinical practice","volume":"12","author":"JA Fern\u00e1ndez-Caballero","year":"2017","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2014.02.011","article-title":"Antiviral therapy of hepatitis C in 2014: do we need resistance testing?","volume":"105","author":"MD Schneider","year":"2014","journal-title":"Antiviral Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.27192","article-title":"Next-generation sequencing sheds light on the natural history of hepatitis C infection in patients who fail treatment","volume":"61","author":"T Abdelrahman","year":"2015","journal-title":"Hepatology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2016.07.042","article-title":"Global genotype distribution of hepatitis C viral infection among people who inject drugs","volume":"65","author":"G Robaeys","year":"2016","journal-title":"J Hepatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"JI Esteban","year":"2008","journal-title":"J Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T23:29:58Z","timestamp":1693783798000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201268"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201268","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]}}}